General MedicationsINTRAVENOUSStandard
ERBITUX
CETUXIMAB
Standard Dose
100mg/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ERBITUX is listed in Drugs@FDA under application 125084 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CETUXIMAB Form and strength VIAL; INTRAVENOUS - 100mg/VIAL Sponsor IMCLONE Submission history Latest submission status date: 2021-09-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview ERBITUX is listed in Drugs@FDA under application 125084 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient CETUXIMAB Form and strength VIAL; INTRAVENOUS - 100mg/VIAL Sponsor IMCLONE Submission history Latest submission status date: 2021-09-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.